Raja Gopoju

425 total citations
15 papers, 338 citations indexed

About

Raja Gopoju is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Raja Gopoju has authored 15 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Raja Gopoju's work include Liver Disease Diagnosis and Treatment (7 papers), Cholesterol and Lipid Metabolism (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Raja Gopoju is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Cholesterol and Lipid Metabolism (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Raja Gopoju collaborates with scholars based in United States, India and China. Raja Gopoju's co-authors include Srigiridhar Kotamraju, Santosh Karnewar, Sathish Babu Vasamsetti, Paradesi Naidu Gollavilli, Jerald Mahesh Kumar, Anantha Koteswararao Kanugula, Shuwei Hu, Yanqiao Zhang, Yanyong Xu and Yingdong Zhu and has published in prestigious journals such as Hepatology, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Raja Gopoju

14 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raja Gopoju United States	8	141	102	66	54	51	15	338
Estefanía de Gregorio Spain	8	195 1.4×	144 1.4×	39 0.6×	73 1.4×	42 0.8×	8	470
Virginia Gutiérrez‐de Juan Spain	7	181 1.3×	129 1.3×	50 0.8×	44 0.8×	36 0.7×	8	369
Ji-Hoon Park South Korea	11	222 1.6×	160 1.6×	56 0.8×	70 1.3×	119 2.3×	32	554
Mingtai Chen China	10	196 1.4×	107 1.0×	40 0.6×	33 0.6×	67 1.3×	44	426
Xinhui Kou China	11	211 1.5×	87 0.9×	39 0.6×	25 0.5×	69 1.4×	14	360
Xianshe Meng China	6	157 1.1×	36 0.4×	85 1.3×	50 0.9×	68 1.3×	9	385
Tingying Jiao China	11	230 1.6×	131 1.3×	65 1.0×	56 1.0×	49 1.0×	15	467
Masayasu Jo Japan	9	126 0.9×	150 1.5×	42 0.6×	73 1.4×	47 0.9×	13	452
Veronika Zámbó Hungary	8	144 1.0×	136 1.3×	27 0.4×	63 1.2×	66 1.3×	15	382
Liufeng Mao China	12	167 1.2×	132 1.3×	66 1.0×	132 2.4×	31 0.6×	23	431

Countries citing papers authored by Raja Gopoju

Since Specialization

Citations

This map shows the geographic impact of Raja Gopoju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raja Gopoju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raja Gopoju more than expected).

Fields of papers citing papers by Raja Gopoju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raja Gopoju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raja Gopoju. The network helps show where Raja Gopoju may publish in the future.

Co-authorship network of co-authors of Raja Gopoju

This figure shows the co-authorship network connecting the top 25 collaborators of Raja Gopoju. A scholar is included among the top collaborators of Raja Gopoju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raja Gopoju. Raja Gopoju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Pan, Xiaoli, et al.. (2025). Loss of hepatic carboxylesterase 3 prevents the development of MASLD in mice. Journal of Lipid Research. 66(10). 100887–100887.

Gopoju, Raja, Jiayou Wang, Xiaoli Pan, et al.. (2024). Hepatic FOXA3 overexpression prevents Western diet–induced obesity and MASH through TGR5. Journal of Lipid Research. 65(4). 100527–100527. 6 indexed citations

Zhu, Yingdong, Xiaoli Pan, Hui Wang, et al.. (2024). Loss of adipose ATF3 promotes adipose tissue lipolysis and the development of MASH. Communications Biology. 7(1). 1300–1300. 2 indexed citations

Pan, Xiaoli, Shuwei Hu, Yanyong Xu, et al.. (2024). Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways. Metabolism. 155. 155909–155909. 7 indexed citations

Zhu, Yingdong, Shuwei Hu, Xiaoli Pan, et al.. (2023). Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis. Cells. 12(15). 2009–2009. 6 indexed citations

Hu, Shuwei, Raja Gopoju, Yanyong Xu, et al.. (2023). Adipocyte retinoic acid receptor α prevents obesity and steatohepatitis by regulating energy expenditure and lipogenesis. Obesity. 32(1). 120–130. 4 indexed citations

Gopoju, Raja, Yanyong Xu, Shuwei Hu, et al.. (2022). Retinoic Acid Receptor Alpha (RARα) in Macrophages Protects from Diet-Induced Atherosclerosis in Mice. Cells. 11(20). 3186–3186. 15 indexed citations

Xu, Yanyong, Raja Gopoju, Shuwei Hu, et al.. (2022). Hepatic retinoic acid receptor alpha mediates all‐trans retinoic acid's effect on diet‐induced hepatosteatosis. Hepatology Communications. 6(10). 2665–2675. 16 indexed citations

Xu, Yanyong, Yingdong Zhu, Shuwei Hu, et al.. (2020). Hepatocyte Nuclear Factor 4α Prevents the Steatosis‐to‐NASH Progression by Regulating p53 and Bile Acid Signaling (in mice). Hepatology. 73(6). 2251–2265. 59 indexed citations

10.

Gopoju, Raja, et al.. (2018). Metformin treatment prevents SREBP2-mediated cholesterol uptake and improves lipid homeostasis during oxidative stress-induced atherosclerosis. Free Radical Biology and Medicine. 118. 85–97. 51 indexed citations

11.

Kumar, Nagiri Ravi, Raja Gopoju, Srigiridhar Kotamraju, et al.. (2018). Novel 1,2,3‐Triazole‐Functionalized 1,2‐Benzothiazine 1,1‐Dioxide Derivatives: Regioselective Synthesis, Biological Evaluation and Docking Studies. ChemistrySelect. 3(8). 2398–2403. 9 indexed citations

12.

Vasamsetti, Sathish Babu, Santosh Karnewar, Raja Gopoju, et al.. (2016). Resveratrol attenuates monocyte-to-macrophage differentiation and associated inflammation via modulation of intracellular GSH homeostasis: Relevance in atherosclerosis. Free Radical Biology and Medicine. 96. 392–405. 59 indexed citations

13.

Karnewar, Santosh, Sathish Babu Vasamsetti, Raja Gopoju, et al.. (2016). Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis. Scientific Reports. 6(1). 24108–24108. 57 indexed citations

14.

Kanugula, Anantha Koteswararao, Paradesi Naidu Gollavilli, Sathish Babu Vasamsetti, et al.. (2014). Statin‐induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms. FEBS Journal. 281(16). 3719–3738. 45 indexed citations

15.

Sabitha, Gowravaram, et al.. (2010). Eco‐friendly, solvent‐free novel one‐pot, three‐component synthesis of quinazolinones at ambient temperature catalyzed by silica gel‐supported phosphomolybdic acid. Journal of Heterocyclic Chemistry. 47(3). 589–593. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact